Clinical Trials Sponsored by National Institute for Cancer Research, Italy

Total 5531 results

Lawson Health Research Institute
Ontario Institute for Cancer Research

Completed

Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer

Head and Neck Cancer | Radiation-Induced Mucositis

Canada
Lawson Health Research Institute
Ontario Institute for Cancer Research

Active, not recruiting

ARREST - A Phase I Study of SABR for Poly-metastatic Disease

Metastatic Cancer

Canada
Ludwig Institute for Cancer Research
Medarex

Terminated

A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma

Synovial Sarcoma

United States
Ludwig Institute for Cancer Research
AgonOx

Withdrawn

Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma

Metastatic Melanoma
Ludwig Institute for Cancer Research
Institute of Cancer Research, United Kingdom

Completed

Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma

Melanoma

United Kingdom, Australia, New Zealand
H. Lee Moffitt Cancer Center and Research Institute
Gateway for Cancer Research

Completed

Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease (Ustekinumab)

Graft vs. Host Disease

United States
Ludwig Institute for Cancer Research
Memorial Sloan Kettering Cancer Center

Completed

Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Cancer

United States
Ludwig Institute for Cancer Research
Memorial Sloan Kettering Cancer Center

Completed

Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250

Kidney Cancer | Renal Cell Carcinoma | Renal Cancer | Kidney Neoplasm

United States
Ludwig Institute for Cancer Research
Memorial Sloan Kettering Cancer Center

Completed

Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.

Kidney Cancer | Clear Cell Renal Cell Carcinoma | Renal Cancer | Renal Cell Carcinoma (RCC) | Renal Neoplasms | Cancer of Kidney | Neoplasms, Kidney

United States
Memorial Sloan Kettering Cancer Center
Ludwig Institute for Cancer Research

Active, not recruiting

Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer

Colorectal Neoplasms | Colorectal Cancer | Colorectal Tumor | COlorectal Carcinoma

United States
Bradford Institute for Health Research
National Institute for Health Research, United Kingdom

Not yet recruiting

Primary Care Management of Osteoporosis in Older Women

Osteoporosis
Dana-Farber Cancer Institute
American Institute for Cancer Research

Recruiting

Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy (CLARITY)

Breast Cancer | Cognitive Change | Chemotherapy Effect | Exercise Therapy

United States
Ludwig Institute for Cancer Research
Roswell Park Cancer Institute

Completed

Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

United States
National Institute for Medical Research, Tanzania

Completed

Evaluation of Presumptive Periodic Treatment (PPT) of Sexually Transmitted Infections (STIs) (PPT)

HIV Infections | Sexually Transmitted Diseases, Bacterial

Tanzania
National Institute for Medical Research, Tanzania

Unknown

Cash Transfer to Adolescent Girls and Young Women to Reduce Sexual Risk Behavior - an Impact Evaluation (CARE)

HIV/AIDS | HSV-2 Infection

Tanzania
National Institute for Medical Research, Tanzania

Completed

Efficacy And Safety Of AL For The Treatment Of Uncomplicated Falciparum Malaria In Mainland Tanzania (TES2016)

Uncomplicated Malaria
Institute of Cancer Research, United Kingdom
National Institute for Health Research, United Kingdom

Unknown

Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer (CALIBER)

Bladder Cancer

United Kingdom
Center for Molecular Medicine

Unknown

Brachytherapy in Treating Patients With Recurrent Prostate Cancer

Prostate Cancer

United States
Center for Outcomes Research and Clinical Epidemiology...
Italian Society of Diabetology

Not yet recruiting

GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial (GOLDEN-AGE)

Diabetes Mellitus, Type 2
Center for Molecular Medicine

Unknown

Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Lung Cancer

United States
Center for Molecular Medicine

Completed

Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer

Pancreatic Cancer

United States
Center for Molecular Medicine

Unknown

Phosphorus 32 in Treating Patients With Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
German Cancer Research Center
National Center for Tumor Diseases, Heidelberg

Recruiting

A Longitudinal Study to Investigate and Develop a Patient-centered and Effective Fatigue Screening (MERLIN)

Cancer-related Fatigue

Germany
M.D. Anderson Cancer Center
National Center for Research Resources (NCRR)

Unknown

Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients

Advanced Cancers

United States
M.D. Anderson Cancer Center
National Center for Research Resources (NCRR)

Unknown

Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol

Advanced Cancers

United States
Jonsson Comprehensive Cancer Center
National Center for Research Resources (NCRR)

Active, not recruiting

Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms

Mental Disorders | Nervous System Diseases | Dyssomnias | Sleep Initiation and Maintenance Disorders | Sleep Disorders

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation

Mucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Stage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Rectal Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer

Adenocarcinoma of the Gastroesophageal Junction | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the Esophagus | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma of the Stomach | Mixed Adenocarcinoma of the Stomach | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer and other conditions

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Angiosarcoma

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer

Colorectal Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | Malignant Mesothelioma | Psychosocial Effects of Cancer and Its Treatment | Thymoma and Thymic Carcinoma

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Withdrawn

Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Serous Cystadenocarcinoma | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Recurrent Ovarian Germ Cell Tumor | Ovarian Papillary Serous Carcinoma | Recurrent Fallopian Tube Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Pilot Study of an Intimacy Enhancement Intervention for Couples Facing Breast Cancer

Breast Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

The Skin Savvy Study: A Behavioral Skin Cancer Prevention Intervention

Skin Cancer Prevention

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

SMART Project in Preventing Skin Cancer (SMART)

Skin Carcinoma

United States
National Cancer Institute (NCI)
Fox Chase Cancer Center

Completed

Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma (Mel47)

Stage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking

Kidney Cancer | Cervical Cancer | Leukemia | Head and Neck Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Tobacco Use Disorder | Lung Cancer | Bladder Cancer | Liver Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer

Colorectal Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

Esophageal Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer

Breast Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer

Lung Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Traditional Print Communication Methods, Simple Electronic Communication Methods, or Usual Care in Increasing How Often Older Women Undergo Colorectal Cancer Screening

Colorectal Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Withdrawn

Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer

Breast Cancer
Fox Chase Cancer Center
National Cancer Institute (NCI)

Withdrawn

Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme

Brain and Central Nervous System Tumors
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Lymphoma | Leukemia

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Withdrawn

Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer

Kidney Cancer
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States

Clinical Trials Sponsored by National Institute for Cancer Research, Italy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations